Status and challenges of anti-vascular endothelial growth factor usage in ophthalmic diseases in China

doi:10.3969/j.issn.1672-3384.2020.12.001

PDF(611 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (12) : 1-5. DOI: 10.3969/j.issn.1672-3384.2020.12.001

Drug Therapy of Eye Diseases

Status and challenges of anti-vascular endothelial growth factor usage in ophthalmic diseases in China

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(12): 1-5 https://doi.org/10.3969/j.issn.1672-3384.2020.12.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(611 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2020-08-25	2020-12-01
Issue Date
2020-12-01

Please choose a citation manager

Content to export